Registry of Toxic Effects of Chemical Substances (RTECS)
Methane, bromo-
RTECS #
PA4900000CAS #
74-83-9Updated
September 201Molecular Weight
94.95Molecular Formula
CH3BrSynonyms
BercemaBrom-methan (German)
Brom-O-Gas
Bromometano (Italian)
Bromomethane
Brom-O-Sol
Bromure de methyle (French)
Bromuro di metile (Italian)
Broommethaan (Dutch)
Celfume
Curafume
Dawson 100
Detia gas EX-M
Dowfume MC-2
Dowfume MC-2 soil fumigant
Dowfume MC-33
Embafume
Fumigant-1 (Obs.)
Halon 1001
Haltox
Iscobrome
Kayafume
Metafume
Methogas
Methyl bromide
Methyl bromide (ACGIH:OSHA)
Methylbromid (German)
Metylu bromek (Polish)
Monobromomethane
Pestmaster (Obs.)
Profume (Obs.)
R 40B1
RCRA waste number U029
Terabol
Terr-O-Cide II
Terr-O-Gas 100
Terr-O-Gas 67
Zytox
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | lymphocyte/human | 95 mg/L | TCMUD8 10,21,1990 |
Cytogenetic Analysis | lung/hamster | 0.05 pph/6H (+enzymatic activation step) | MUREAV 652,122,2008 |
Cytogenetic Analysis | lung/hamster | 0.1 pph/6H (-enzymatic activation step) | MUREAV 652,122,2008 |
micronucleus test | inhalation/rat | 338 ppm/6H/14D- intermittent | MUREAV 164,269,1986 |
micronucleus test | inhalation/mouse | 100 ppm/6H/14D- intermittent | NTPTR* NTP-TR-385,1992 |
mutation in mammalian somatic cells | lymphocyte/mouse | 300 µg/L | MUREAV 155,41,1985 |
mutation in microorganisms | /Salmonella typhimurium | 400 ppm (+enzymatic activation step) | DHEFDK FDA-78-1046,1978 |
mutation in microorganisms | /Salmonella typhimurium | 5000 mg/m3 (-enzymatic activation step) | MUREAV 116,185,1983 |
mutation in microorganisms | /Klebsiella pneumoniae | 4750 mg/m3 (-enzymatic activation step) | MUREAV 155,41,1985 |
other mutation test systems | /Salmonella typhimurium | 3 pph | ENMUDM 9,171,1987 |
sex chromosome loss and nondisjunction | inhalation/Drosophila melanogaster | 150 mg/m3/6H | MUREAV 113,272,1983 |
sister chromatid exchange | inhalation/mouse | 200 ppm/6H/14D- intermittent | NTPTR* NTP-TR-385,1992 |
sister chromatid exchange | lymphocyte/human | 43000 ppm | ENMUDM 7(Suppl 3),48,1985 |
sister chromatid exchange | lymphocyte/human | 5 mg/L | TCMUD8 10,21,1990 |
specific locus test | inhalation/Drosophila melanogaster | 8 mg/L/1H-continuous | MUREAV 192,131,1987 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/rat | 300 mg/kg (6-15D pregnant) | Reproductive: Other effects on female | FCTOD7 36,421,1998 |
oral/rabbit | 130 mg/kg (6-18D pregnant) | Reproductive: Other effects on female | FCTOD7 36,421,1998 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/rat | lowest published toxic concentration: 30 ppm/6H/2.5Y- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Olfaction: Tumors | NTIS** OTS0559186 |
oral/rat | lowest published toxic dose: 3250 mg/kg/13W- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Gastrointestinal: Peritonitis Gastrointestinal: Tumors | TXAPA9 72,262,1984 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/child | Lowest published lethal concentration: 1 gm/m3/2H | Blood: Change in clotting factors | NHOZAX 23,241,1969 |
inhalation/guinea pig | Lowest published lethal concentration: 300 ppm/9H | Behavioral: Muscle weakness Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis) Skin and Appendages: Other: Hair | XPHBAO 185,1,1929 |
inhalation/guinea pig | Lowest published lethal concentration: 1200 mg/m3/9H | Lung, Thorax, or Respiration: Other changes | VCVGH* -,575,1990 |
inhalation/human | lowest published toxic concentration: 35 ppm | Behavioral: Anorexia (human) Gastrointestinal: Nausea or vomiting Skin: After topical application: Corrosive | INMEAF 11,575,1942 |
inhalation/human | Lowest published lethal concentration: 30000 mg/m3 | VCVGH* -,575,1990 | |
inhalation/man | Lowest published lethal concentration: 60000 ppm/2H | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Respiratory stimulation Gastrointestinal: Nausea or vomiting | BJIMAG 2,24,1945 |
inhalation/mouse | lowest published toxic concentration: 800 mg/m3 | Behavioral: General anesthetic | VCVGH* -,574,1990 |
inhalation/mouse | Lowest published lethal concentration: 5200 mg/m3 | Behavioral: Ataxia | VCVGH* -,574,1990 |
inhalation/mouse | lethal concentration (50 percent kill): 1540 mg/m3/2H | VCVGH* -,574,1990 | |
inhalation/mouse | lethal concentration (50 percent kill): 4680 mg/m3/1H | VCVGH* -,574,1990 | |
inhalation/mouse | lethal concentration (50 percent kill): 1700 ppm/30M | ENTOX* -,71,2005 | |
inhalation/mouse | lethal concentration (50 percent kill): 405 ppm/4H | ENTOX* -,71,2005 | |
inhalation/rabbit | Lowest published lethal concentration: 1000 mg/m3/30M | VCVGH* -,575,1990 | |
inhalation/rabbit | lethal concentration (50 percent kill): 28900 mg/m3/30M | FATOBP 8,140,1973 | |
inhalation/rat | lethal concentration (50 percent kill): 302 ppm/8H | Behavioral: Change in motor activity (specific assay) Nutritional and Gross Metabolic: Weight loss or decreased weight gain Nutritional and Gross Metabolic: Body temperature decrease | TXAPA9 81,183,1985 |
inhalation/rat | lethal concentration (50 percent kill): 2250 mg/m3/2H | VCVGH* -,575,1990 | |
inhalation/rat | lethal concentration (50 percent kill): 2833 ppm/30M | ENTOX* -,71,2005 | |
inhalation/rat | lethal concentration (50 percent kill): 302 ppm/8H | ENTOX* -,71,2005 | |
intraperitoneal/mouse | lethal dose (50 percent kill): 313 mg/kg | VCVGH* -,572,1990 | |
oral/Dog | lowest published lethal dose: 500 mg/kg | Cardiac: Pulse rate increased without fall in BP Gastrointestinal: Nausea or vomiting Nutritional and Gross Metabolic: Body temperature decrease | NTIS** OTS0528834 |
oral/rat | lethal dose (50 percent kill): 214 mg/kg | TXAPA9 72,262,1984 | |
skin/human | lowest published toxic dose: 35 gm/m3/40M- intermittent | Skin: After systemic exposure: Dermatitis, irritative | ARDEAC 124,917,1988 |
subcutaneous/rat | lethal dose (50 percent kill): 135 mg/kg | INHEAO 26,101,1988 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/guinea pig | lowest published toxic concentration: 850 mg/m3/8H/26W- intermittent | Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change Lung, Thorax, or Respiration: Chronic pulmonary edema or congestion Lung, Thorax, or Respiration: Dyspnea | JIHTAB 22,218,1940 |
inhalation/monkey | lowest published toxic concentration: 250 mg/m3/8H/26W- intermittent | Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change Behavioral: Convulsions or effect on seizure threshold | JIHTAB 22,218,1940 |
inhalation/mouse | lowest published toxic concentration: 200 ppm/6H/14D- intermittent | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTPTR* NTP-TR-385,1992 |
inhalation/mouse | lowest published toxic concentration: 120 ppm/6H/13W- intermittent | Behavioral: Muscle contraction or spasticity Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTPTR* NTP-TR-385,1992 |
inhalation/mouse | lowest published toxic concentration: 160 ppm/6H/6W- intermittent | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Endocrine: Other changes Blood: Changes in spleen | FAATDF 11,594,1988 |
inhalation/rabbit | lowest published toxic concentration: 130 mg/m3/8H/26W- intermittent | Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis) Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | JIHTAB 22,218,1940 |
inhalation/rat | lowest published toxic concentration: 120 ppm/6H/13W- intermittent | Blood: Pigmented or nucleated red blood cells Blood: Changes in erythrocyte (RBC) count Nutritional and Gross Metabolic: Weight loss or decreased weight gain | NTPTR* NTP-TR-385,1992 |
inhalation/rat | lowest published toxic concentration: 150 ppm/6H/5D- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases Biochemical: Metabolism (intermediary): Amino acids (including renal excretion) | TXAPA9 112,120,1992 |
inhalation/rat | lowest published toxic concentration: 160 ppm/6H/6W- intermittent | Brain and Coverings: Other degenerative changes Olfaction: Other olfaction effects Cardiac: Other changes | FAATDF 11,594,1988 |
inhalation/rat | lowest published toxic concentration: 300 ppm/4H/3W- intermittent | Behavioral: Somnolence (general depressed activity) Behavioral: Ataxia Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | TOLED5 6,293,1980 |
inhalation/rat | lowest published toxic concentration: 290 ppm/4W- intermittent | Brain and Coverings: Other degenerative changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes | NRTXDN 28,252,2007 |
oral/rat | lowest published toxic dose: 21840 mg/kg/2Y- continuous | Kidney, Ureter, and Bladder: Other changes in urine composition Skin and Appendages: Other: Hair Nutritional and Gross Metabolic: Weight loss or decreased weight gain | FCTOD7 28,109,1990 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 1 ppm (skin) | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Not classifiable as a human carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Limited Evidence | IMEMDT 41,187,1986 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Limited Evidence | IMEMDT 71,721,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 41,187,1986 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 71,721,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 3 | IMEMDT 71,721,1999 |
TOXICOLOGY REVIEW | TOLED5 134,3,2002 | |
TOXICOLOGY REVIEW | MUREAV 543,201,2003 | |
TOXICOLOGY REVIEW | MUTAEX 21,93,2006 | |
TOXICOLOGY REVIEW | CHHSA* 9,6,2002 | |
TOXICOLOGY REVIEW | ENTOX* -,71,2005 | |
TOXICOLOGY REVIEW | MUREAV 584,1,2005 | |
TOXICOLOGY REVIEW | TOPADD 33,517,2005 | |
TOXICOLOGY REVIEW | HUTOX* -,561,1996 | |
TOXICOLOGY REVIEW | HUTOX* -,577,1996 | |
TOXICOLOGY REVIEW | MUREAV 543,251,2003 | |
TOXICOLOGY REVIEW | FCTOD7 47,1287,2009 | |
TOXICOLOGY REVIEW | MUREAV 590,1,2005 | |
TOXICOLOGY REVIEW | NEUCL* 23,377,2005 | |
TOXICOLOGY REVIEW | NTAPM* -,239,1995 | |
TOXICOLOGY REVIEW | NTAPM* -,629,1995 | |
TOXICOLOGY REVIEW | MUTAEX 26,19,2011 | |
TOXICOLOGY REVIEW | REPTED 31,392,2011 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION | FEREAC 54,7740,1989 | |
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF PESTICIDES | Supported | RBREV* -,132,1998 |
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 15 ppm (60 mg/m3) (skin) | DTLWS* 3,23,1973 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-ARAB Republic of Egypt | time-weighted average 5 ppm (20 mg/m3), Skin, JAN1993 | |
Occupational Exposure Limit-AUSTRALIA | time-weighted average 5 ppm (19 mg/m3), JUL2008 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 5 ppm (19 mg/m3), Skin, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 5 ppm (20 mg/m3), skin, MAY2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 5 ppm (20 mg/m3), short term exposure limit 10 ppm (39 mg/m3), skin, NOV2011 | |
Occupational Exposure Limit-FRANCE | VME 5 ppm (20 mg/m3), FEB2006 | |
Occupational Exposure Limit-HUNGARY | time-weighted average 10 mg/m3, short term exposure limit 10 mg/m3, Skin, SEP2000 | |
Occupational Exposure Limit-ICELAND | time-weighted average 5 ppm (20 mg/m3), skin, NOV2011 | |
Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 1 ppm (3.89 mg/m3), skin, MAY2012 | |
Occupational Exposure Limit-KOREA | time-weighted average 5 ppm (20 mg/m3), skin, 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 15 ppm (20 mg/m3);short term exposure limit 15 ppm (60 mg/m3) (skin), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 5 ppm (19 mg/m3), skin, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 5 ppm (20 mg/m3), JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 1 ppm (4 mg/m3), JUL2005 | |
Occupational Exposure Limit-POLAND | MAC(time-weighted average) 5 mg/m3, MAC(short term exposure limit) 40 mg/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | time-weighted average 1 mg/m3, short term exposure limit 3 mg/m3, JUN2003 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 5 ppm (19 mg/m3);short term exposure limit 10 ppm (40 mg/m3), Skin, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 1 ppm (3.9 mg/m3), KZG-week 2 ppm (7.8 mg/m3), JAN2011 | |
Occupational Exposure Limit-THAILAND | time-weighted average 20 ppm (80 mg/m3), JAN1993 | |
Occupational Exposure Limit-THE NETHERLANDS | MAC-TGG 1 mg/m3, Skin, 2003 | |
Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 20 ppm (80 mg/m3), Skin, JAN1993 | |
Occupational Exposure Limit-TURKEY | time-weighted average 20 ppm (80 mg/m3), JAN1993 | |
Occupational Exposure Limit-UNITED KINGDOM | time-weighted average 5 ppm (20 mg/m3);short term exposure limit 15 ppm (59 mg/m3), skin, OCT2007 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | ceiling concentration 20 ppm (80 mg/m3) (skin) | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | ceiling concentration 20 ppm (80 mg/m3) (skin) | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | ceiling concentration 20 ppm (80 mg/m3) (skin) | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | ceiling concentration 20 ppm (80 mg/m3) (skin) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO METHYL BROMIDE-air | Carcinogen lowest feasible concentration | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code M0420; Number of Industries 4; Total Number of Facilities 513; Number of Occupations 5; Total Number of Employees Exposed 5603; Total Number of Female Employees Exposed 975 | |
National Occupational Hazard Survey 1974 | Hazard Code M0420; Number of Industries 10; Total Number of Facilities 597; Number of Occupations 14; Total Number of Employees Exposed 15899 |
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division